United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 30, 2026 · Filed May 1, 2026

On Apr 30, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$572.60 for US$5.73M under a trading plan, leaving 18,876 shares. Filed May 1, 2026 (Form 4).

Sold
10,000 shares
Price
US$572.60 average (US$569.24 to US$578.76)
Value
US$5.73M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 30, 2026Common StockSale262US$569.2428,614Direct
Apr 30, 2026Common StockSale484US$570.1928,130Direct
Apr 30, 2026Common StockSale2,940US$571.2325,190Direct
Apr 30, 2026Common StockSale3,034US$572.0022,156Direct
Apr 30, 2026Common StockSale880US$573.0021,276Direct
Apr 30, 2026Common StockSale887US$574.0720,389Direct
Apr 30, 2026Common StockSale273US$574.9620,116Direct
Apr 30, 2026Common StockSale486US$576.2419,630Direct
Apr 30, 2026Common StockSale336US$577.2419,294Direct
Apr 30, 2026Common StockSale378US$578.0718,916Direct
Apr 30, 2026Common StockSale40US$578.7618,876Direct

Source

View original at SEC

Related